Procaps Group S.A. (PROC)
USD 1.01
(0.0%)
USD 1.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | 42.54 Million USD | 142.18% |
| 2021 | -100.86 Million USD | -865.47% |
| 2020 | -10.44 Million USD | 38.59% |
| 2019 | -17.01 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | 26.95 Million USD | 307.11% |
| 2023 Q3 | 8.19 Million USD | -69.6% |
| 2023 Q1 | 6.62 Million USD | -36.54% |
| 2022 Q2 | -6.91 Million USD | -142.07% |
| 2022 Q1 | 16.44 Million USD | 135.53% |
| 2022 Q4 | 10.43 Million USD | -53.79% |
| 2022 FY | 42.54 Million USD | 142.18% |
| 2022 Q3 | 22.58 Million USD | 426.35% |
| 2021 Q4 | -46.29 Million USD | -26.48% |
| 2021 Q3 | -36.6 Million USD | -5539.75% |
| 2021 Q1 | -17.31 Million USD | -283.37% |
| 2021 FY | -100.86 Million USD | -865.47% |
| 2021 Q2 | -649 Thousand USD | 96.25% |
| 2020 Q1 | -27.58 Million USD | -548.71% |
| 2020 Q4 | 9.44 Million USD | 1074.72% |
| 2020 Q3 | -969 Thousand USD | -111.19% |
| 2020 Q2 | 8.66 Million USD | 131.4% |
| 2020 FY | -10.44 Million USD | 38.59% |
| 2019 FY | -17.01 Million USD | 0.0% |
| 2019 Q2 | -4.25 Million USD | 0.0% |
| 2019 Q1 | -4.25 Million USD | 0.0% |
| 2019 Q4 | -4.25 Million USD | 0.0% |
| 2019 Q3 | -4.25 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -209.24 Million USD | 120.33% |
| Theratechnologies Inc. | -23.95 Million USD | 277.568% |
| Safety Shot Inc | -15.08 Million USD | 382.039% |
| Cosmos Health Inc. | -18.54 Million USD | 329.417% |
| Cronos Group Inc. | -73.96 Million USD | 157.515% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 104.244% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 200.808% |
| Organogenesis Holdings Inc. | 4.94 Million USD | -760.263% |
| Universe Pharmaceuticals INC | -6.16 Million USD | 790.241% |
| ProPhase Labs, Inc. | -16.78 Million USD | 353.486% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | 979.835% |
| Dynavax Technologies Corporation | -6.38 Million USD | 765.832% |
| Radius Health, Inc. | -25.79 Million USD | 264.941% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | 1472.908% |
| Alvotech | -551.73 Million USD | 107.71% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | 1044.065% |
| Alpha Teknova, Inc. | -36.78 Million USD | 215.661% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 130.457% |
| SCYNEXIS, Inc. | 67.04 Million USD | 36.546% |
| Harrow Health, Inc. | -24.41 Million USD | 274.266% |
| Biofrontera Inc. | -20.13 Million USD | 311.316% |
| DURECT Corporation | -27.62 Million USD | 253.997% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | -3132.523% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | -126.53% |
| OptiNose, Inc. | -35.48 Million USD | 219.888% |
| RedHill Biopharma Ltd. | 23.91 Million USD | -77.873% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | 640.534% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | 777.462% |
| SIGA Technologies, Inc. | 68.06 Million USD | 37.504% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | -254.116% |
| Shineco, Inc. | -22.44 Million USD | 289.496% |
| Phibro Animal Health Corporation | 2.41 Million USD | -1660.762% |
| TherapeuticsMD, Inc. | -10.27 Million USD | 513.894% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | 1088.88% |
| Viatris Inc. | 54.7 Million USD | 22.23% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | 1044.065% |
| Rockwell Medical, Inc. | -8.43 Million USD | 604.088% |
| Incannex Healthcare Limited | -18.45 Million USD | 330.457% |
| Aytu BioPharma, Inc. | -15.84 Million USD | 368.493% |
| Tilray Brands, Inc. | -244.98 Million USD | 117.365% |
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 11.66% |
| PetIQ, Inc. | 2.13 Million USD | -1896.246% |
| Silver Spike Investment Corp. | 7.34 Million USD | -479.556% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 82.964% |
| Journey Medical Corporation | -3.85 Million USD | 1204.075% |
| Alimera Sciences, Inc. | -20.13 Million USD | 311.305% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | 621.12% |
| Assertio Holdings, Inc. | -331.94 Million USD | 112.815% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | 745.257% |
| Embecta Corp. | 70.4 Million USD | 39.574% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 312.092% |
| Procaps Group, S.A. | 42.54 Million USD | 0.0% |
| PainReform Ltd. | -9.34 Million USD | 555.265% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 126.542% |
| Hempacco Co., Inc. | -13.12 Million USD | 424.088% |
| Talphera, Inc. | -18.39 Million USD | 331.233% |
| Pacira BioSciences, Inc. | 41.95 Million USD | -1.394% |
| Alvotech | -551.73 Million USD | 107.71% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 86.977% |
| Kamada Ltd. | 8.28 Million USD | -413.52% |
| Indivior PLC | 2 Million USD | -2027.0% |
| Currenc Group, Inc. | -15.3 Million USD | 377.92% |
| Evoke Pharma, Inc. | -7.79 Million USD | 645.924% |
| Flora Growth Corp. | -57.03 Million USD | 174.584% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 312.092% |
| Evolus, Inc. | -61.68 Million USD | 168.963% |
| HUTCHMED (China) Limited | 100.78 Million USD | 57.789% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 69.072% |
| Akanda Corp. | -32.27 Million USD | 231.805% |